BharatBiotech’s Covaxin is now available for children of age 6+

The Drugs Controller General of India (DCGI) has given BharatBiotech’s Covaxin restricted emergency use authorisation. This vaccine can now be used for children between the ages of 6 to 12.

The Drugs Controller General of India (DCGI) has given BharatBiotech’s Covaxin restricted emergency use authorisation. This vaccine can now be used for children between the ages of 6 to 12. Along with Covaxin, Union Health Minister Mansukh Mandaviya announced the approval of Corbevax and ZyCov-D vaccines for children.

This action is taken on the recommendation of the Subject Expert Committee (SEC) on Covid-19 by the Central Drugs Standard Control Organisation or CDSCO. The SEC had last week received applications from BharatBiotech’s Covaxin (for age group 6 to 12) and from Biological E’s Corbevax (for age 5 to 12).

The SEC gave BharatBiotech the no-objection certificate after a two-month-long deliberation on the topic. The DCGI has also asked BharatBiotech to share their safety data and data on adverse events twice every month for 2 months. After these two months, the vaccine maker can monthly send 1 report for 5 consecutive months. 

In December 2021 the DCGI had given Emergency Use Listing (EUL) to Covaxin to be used for ages 12 to 18. Corbevax on the other hand has been used for the age group 12 to 14. Even Zydus Cadila’s two-dose regimen ZycovD vaccine against Covid-19 has been approved for children over the age of 12 years. ZycovD showed a 66.6% efficacy in the interim analysis during Phase 3 clinical trials. 

The vaccination drive started on March 1st for people above the age of 60 years. A month later, on April 1st, the vaccination drive began for people over the age of 45. From May 1st onwards, a vaccination drive for every adult (18 years of age) began. Next came the age group of 15 to 18, for whom the vaccination phase began on January 3rd.

Tags : #BharatBiotech #Covaxin #vaccination #Children-Vaccination #vaccine #Covid-19 #Corbevax #Zycov-D #UnionHealthMinister #MansukhMandaviya #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Sanmarg Auto++: Revolutionizing Mobility at Kolkata’s Biggest Auto FairMarch 22, 2025
39th Prof. M. Viswanathan Oration Highlights Strategies to Prevent Diabetic Foot AmputationsMarch 22, 2025
Catapulting funding crisis into opportunity by getting on track to end TB and tobacco useMarch 22, 2025
University of Leeds Opens Applications for MSc in Sustainable Agriculture & Food Production for Indian StudentsMarch 21, 2025
Crompton Reimagines Lighting with Launch of INFINIA - 20% Extra Brightness & SlimO - Ultra-Sleek Appeal!March 21, 2025
March 21, 2025
World Down Syndrome Day: Why India is Still Failing Its Special ChildrenMarch 21, 2025
The Digital Delusion: How Social Media Is Rewiring Your RealityMarch 21, 2025
Can Giving Blood Lower Your Risk of Heart Disease and Diabetes? Find OutMarch 21, 2025
Embracing Extra Chromosomes: Individuals with Down Syndrome face health challenges, stigma, and limited care, but early intervention and inclusion can transform their livesMarch 20, 2025
Why Doctors May Soon Prescribe Walks in the Park Instead of PillsMarch 20, 2025
Today some of the LIC agents met the Hon’ble Leader of Opposition and raised certain issues.March 20, 2025
Sarvodaya Healthcare, in partnership with Oncidium Foundation, becomes India’s first to offer Nuclear Therapy for cancer patientsMarch 20, 2025
Sarvodaya Healthcare, in partnership with Oncidium Foundation, becomes India’s first to offer Nuclear Therapy for cancer patientsMarch 20, 2025
Think Alcohol Is Bad for You? New Research Might Prove You WrongMarch 20, 2025
Lilly Launches Mounjaro® (tirzepatide), offering a new option for the treatment of obesity and type 2 diabetesMarch 20, 2025
How can we leave those behind who are at higher TB risk?March 20, 2025
The Global Tuberculosis Fight: Why Prevention Holds Key to EradicationMarch 20, 2025
Chew Your Way to a Sharper Mind: The Surprising Brain Hack No One Told You AboutMarch 20, 2025
Danger of substandard and falsified medical products is real and growingMarch 19, 2025